High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$64.5M
$64,451,693
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| KYMR |
Kymera Therapeutics, Inc.
|
COO
10b5-1 Sell
|
2026-03-11 | $2,145,673Largex3 | S | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
COO
Sell to Cover
|
2026-03-04 | $334,272x4 | S | Form 4 |
|
KYMR
S
Kymera Therapeutics, Inc.
Gollob Jared
• Officer • Chief Medical Officer
Sell to Cover
2026-03-04
$417,521x4
|
||||||
| KYMR |
Kymera Therapeutics, Inc.
|
Officer • Chief Medical Officer
Sell to Cover
|
2026-03-04 | $417,521x4 | S | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
CFO
Sell to Cover
|
2026-03-04 | $417,521x4 | S | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
Director
10b5-1 Sell
|
2026-03-02 | $7,378,583Whalex2 | S | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
COO
Sell to Cover
|
2026-03-02 | $181,322x3 | S | Form 4 |
|
KYMR
S
Kymera Therapeutics, Inc.
Gollob Jared
• Officer • Chief Medical Officer
Sell to Cover
2026-03-02
$499,148x3
|
||||||
| KYMR |
Kymera Therapeutics, Inc.
|
Officer • Chief Medical Officer
Sell to Cover
|
2026-03-02 | $499,148x3 | S | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
CFO
Sell to Cover
|
2026-03-02 | $673,710x3 | S | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
CEO
10b5-1 Sell
|
2026-02-25 | $2,707,813Largex5 | S | Form 4 |
|
KYMR
S
Kymera Therapeutics, Inc.
Esposito Pamela
• Director
10b5-1 SellΔOwn -76.0%
2026-02-20
$218,270x2
|
||||||
| KYMR |
Kymera Therapeutics, Inc.
|
Director
10b5-1 SellΔOwn -76.0%
|
2026-02-20 | $218,270x2 | S | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
Director
10b5-1 Sell
|
2026-01-20 | $373,521x3 | S | Form 4 |
|
KYMR
S
Kymera Therapeutics, Inc.
Esposito Pamela
• Director
10b5-1 SellΔOwn -52.6%
2025-12-17
$2,264,480Largex4
|
||||||
| KYMR |
Kymera Therapeutics, Inc.
|
Director
10b5-1 SellΔOwn -52.6%
|
2025-12-17 | $2,264,480Largex4 | S | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
Director
Discretionary Sell
|
2025-12-12 | $61,725x2 | S | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
Director
Discretionary Sell
|
2025-12-11 | $556,594x2 | S | Form 4 |
|
KYMR
S
Kymera Therapeutics, Inc.
Booth Bruce
• Director
Discretionary Sell
2025-12-10
$21,080,724MEGAx10
|
||||||
| KYMR |
Kymera Therapeutics, Inc.
|
Director
Discretionary Sell
|
2025-12-10 | $21,080,724MEGAx10 | S | Form 4 |
|
KYMR
S
Kymera Therapeutics, Inc.
Albers Jeffrey W.
• Director
10b5-1 SellΔOwn -55.0%
2025-12-08
$448,823x2
|
||||||
| KYMR |
Kymera Therapeutics, Inc.
|
Director
10b5-1 SellΔOwn -55.0%
|
2025-12-08 | $448,823x2 | S | Form 4 |
|
KYMR
S
Kymera Therapeutics, Inc.
Gollob Jared
• Officer • Chief Medical Officer
10b5-1 Sell
2025-12-08
$4,371,833Largex6
|
||||||
| KYMR |
Kymera Therapeutics, Inc.
|
Officer • Chief Medical Officer
10b5-1 Sell
|
2025-12-08 | $4,371,833Largex6 | S | Form 4 |
|
KYMR
S
Kymera Therapeutics, Inc.
Mainolfi Nello
• CEO
10b5-1 SellΔOwn -13.2%
2025-12-08
$8,917,000Whale
|
||||||
| KYMR |
Kymera Therapeutics, Inc.
|
CEO
10b5-1 SellΔOwn -13.2%
|
2025-12-08 | $8,917,000Whale | S | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
CEO
10b5-1 Sell
|
2025-10-29 | $1,829,737Largex3 | S | Form 4 |
|
KYMR
S
Kymera Therapeutics, Inc.
Gollob Jared
• Officer • Chief Medical Officer
10b5-1 Sell
2025-10-15
$3,659,254Largex4
|
||||||
| KYMR |
Kymera Therapeutics, Inc.
|
Officer • Chief Medical Officer
10b5-1 Sell
|
2025-10-15 | $3,659,254Largex4 | S | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
Director
10b5-1 Sell
|
2025-10-13 | $295,949 | S | Form 4 |
|
KYMR
S
Kymera Therapeutics, Inc.
Gollob Jared
• Officer • Chief Medical Officer
10b5-1 Sell
2025-10-13
$186,840
|
||||||
| KYMR |
Kymera Therapeutics, Inc.
|
Officer • Chief Medical Officer
10b5-1 Sell
|
2025-10-13 | $186,840 | S | Form 4 |
|
KYMR
S
Kymera Therapeutics, Inc.
Jacobs Bruce N.
• CFO
10b5-1 SellΔOwn -25.8%
2025-09-17
$3,961,380Large
|
||||||
| KYMR |
Kymera Therapeutics, Inc.
|
CFO
10b5-1 SellΔOwn -25.8%
|
2025-09-17 | $3,961,380Large | S | Form 4 |
| KYMR |
Kymera Therapeutics, Inc.
|
CEO
10b5-1 Sell
|
2025-09-16 | $1,470,000Large | S | Form 4 |